Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420756 · ClinicalTrials.gov registry record
Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
A clinical trial of Mild Cognitive Impairment and Dementia, sponsored by American College of Radiology.
- Completed
- Registry status
- 18,488
- Enrollment target
- 2
- Study locations
NCT02420756 is a study of Mild Cognitive Impairment and Dementia that has completed, run by American College of Radiology. The registered enrollment target is 18,488 participants, above the 1,180-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (1467% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT02420756, a study of Mild Cognitive Impairment and Dementia, has completed, sponsored by American College of Radiology.
- COMPLETED
- Registry status
- 18,488 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. The study will be performed in accordance with the Center for Medicare \& Medicaid Services (CMS) policy of Coverage with Evidence Development (CED) in Medicare beneficiaries who meet the Appropriate Use Criteria (AUC) for amyloid PET (Johnson et al. 2013). Our hypothesis is that amyloid PET will decrease uncertainty and increase confidence in the underlying cause of cognitive impairment, that this will translate into earlier counseling and interventions in these domains, and that these interventions will lead to improved outcomes.
Conditions Studied
Interventions
- DEVICE PET Scan
Study Locations (2)
Pennsylvania
- American College of Radiology Imaging Network - Philadelphia
- Https://Www.Ideas-Study.Org/Site-Locator/ - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,488 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02420756
The ClinicalTrials.gov registry entry for NCT02420756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18,488 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,180-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (1467% higher). The listed sponsor is American College of Radiology, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which PET Scan is the first listed.
NCT02420756 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02420756 about?
NCT02420756 is a clinical study titled "Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study". The Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes. The study will be performed in accordance with the Center for Medicare \& Medicaid Services (CMS) policy of Coverage with ...
What is the current status of trial NCT02420756?
This trial is currently completed. The enrollment target is 18,488 participants. The study started on 2016-02. Estimated completion is 2017-12.
What conditions does trial NCT02420756 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Alzheimers Disease.
What interventions are being tested in trial NCT02420756?
The interventions under investigation include: PET Scan (DEVICE).
Who is sponsoring clinical trial NCT02420756?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02420756 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.